... Bioorganic & Medicinal Chemistry Letters. Volume 23, Issue 13, 1 July 2013, Pages 3927–3934. ... 4 Peripheral and central adverse effects of the partial α4β2 nAChR agonist 3, a smoking cessation medicine, may also be attributed to suboptimal subtype selectivity. 5. ...